Growth characteristics of the veterinary vaccine candidate ChimeriVax-West Nile (WN) virus in Aedes and Culex mosquitoes
- PMID: 12941006
- DOI: 10.1046/j.1365-2915.2003.00438.x
Growth characteristics of the veterinary vaccine candidate ChimeriVax-West Nile (WN) virus in Aedes and Culex mosquitoes
Abstract
In 1999 West Nile (WN) virus was introduced to North America where this flavivirus has spread rapidly among wildlife (especially birds) transmitted by various species of mosquitoes (Diptera: Culicidae). Increasing numbers of cases and deaths among humans, horses and other domestic animals require development of effective vaccines. 'ChimeriVax-West Nile(vet)' is being developed for use as a veterinary vaccine to protect against WN infection. This chimeric virus contains the pre-membrane (prM) and envelope (E) genes from the wild-type WN NY99 virus (isolated from a flamingo in New York zoo during the 1999 WN epidemic) in the backbone of yellow fever (YF) 17D vaccine virus. Replication kinetics of ChimeriVax-WN(vet) virus were evaluated in mosquito cell culture (Aedes albopictus C6/36), in WN vector mosquitoes [Culex tritaeniorhynchus Giles, Cx. nigripalpus Theobald and Cx. quinquefasciatus Say (Diptera: Culicidae)] and in YF vectors [Aedes aegypti (L) and Ae. albopictus (Skuse)], to determine whether these mosquitoes become infected through feeding on a viraemic vaccine, and their potential infectivity to transmit the virus. Growth of ChimeriVax-WN(vet) virus was found to be restricted in mosquitoes, compared to WN virus in Ae. albopictus C6/36 cells. When inoculated intrathoracically, ChimeriVax-WN(vet) and YF 17D viruses did not replicate in Cx. tritaeniorhynchus or Cx. nigripalpus; replication was very restricted compared to the wild-type WN virus in Cx. quinquefasciatus, Ae. aegypti and Ae. albopictus. When fed on hanging drops with ChimeriVax-WN(vet) virus (7.7 log10 PFU/mL), none of the Culex mosquitoes became infected; one Ae. albopictus and 10% of the Ae. aegypti became infected, but the titre was very low and virus did not disseminate to head tissue. ChimeriVax-WN(vet) virus had a replication profile similar to that of the attenuated vaccine virus YF 17D, which is not transmitted by mosquitoes. These results suggest that the natural mosquito vectors of WN and YF viruses, which may incidentally take a bloodmeal from a vaccinated host, will not become infected with ChimeriVax-WN(vet) virus.
Similar articles
-
Growth characteristics of the chimeric Japanese encephalitis virus vaccine candidate, ChimeriVax-JE (YF/JE SA14--14--2), in Culex tritaeniorhynchus, Aedes albopictus, and Aedes aegypti mosquitoes.Am J Trop Med Hyg. 2000 Apr;62(4):480-4. doi: 10.4269/ajtmh.2000.62.480. Am J Trop Med Hyg. 2000. PMID: 11220763
-
Growth characteristics of ChimeriVax-DEN2 vaccine virus in Aedes aegypti and Aedes albopictus mosquitoes.Am J Trop Med Hyg. 2002 Sep;67(3):260-5. doi: 10.4269/ajtmh.2002.67.260. Am J Trop Med Hyg. 2002. PMID: 12408664
-
Analysis of the replication kinetics of the ChimeriVax-DEN 1, 2, 3, 4 tetravalent virus mixture in Aedes aegypti by real-time reverse transcriptase-polymerase chain reaction.Am J Trop Med Hyg. 2004 Jan;70(1):89-97. Am J Trop Med Hyg. 2004. PMID: 14971704
-
West Nile virus vaccine.Curr Drug Targets Infect Disord. 2001 May;1(1):37-50. doi: 10.2174/1568005013343254. Curr Drug Targets Infect Disord. 2001. PMID: 12455232 Review.
-
Prospects for development of a vaccine against the West Nile virus.Ann N Y Acad Sci. 2001 Dec;951:1-12. doi: 10.1111/j.1749-6632.2001.tb02680.x. Ann N Y Acad Sci. 2001. PMID: 11797767 Review.
Cited by
-
A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.J Virol. 2004 Sep;78(18):9998-10008. doi: 10.1128/JVI.78.18.9998-10008.2004. J Virol. 2004. PMID: 15331733 Free PMC article.
-
Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus.Viruses. 2013 Dec 9;5(12):3048-70. doi: 10.3390/v5123048. Viruses. 2013. PMID: 24351795 Free PMC article. Review.
-
Chimeric tick-borne encephalitis/dengue virus is attenuated in Ixodes scapularis ticks and Aedes aegypti mosquitoes.Vector Borne Zoonotic Dis. 2011 Jun;11(6):665-74. doi: 10.1089/vbz.2010.0179. Epub 2010 Dec 13. Vector Borne Zoonotic Dis. 2011. PMID: 21142950 Free PMC article.
-
Structural gene (prME) chimeras of St Louis encephalitis virus and West Nile virus exhibit altered in vitro cytopathic and growth phenotypes.J Gen Virol. 2012 Jan;93(Pt 1):39-49. doi: 10.1099/vir.0.033159-0. Epub 2011 Sep 21. J Gen Virol. 2012. PMID: 21940408 Free PMC article.
-
Phase II, randomized, double-blind, placebo-controlled, multicenter study to investigate the immunogenicity and safety of a West Nile virus vaccine in healthy adults.J Infect Dis. 2011 Jan 1;203(1):75-84. doi: 10.1093/infdis/jiq003. J Infect Dis. 2011. PMID: 21148499 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical